Difference between revisions of "Improve Screening for Infectious Disease among Those with SUDs"
| Line 1: | Line 1: | ||
| − | __NOTOC__<div class="mw-parser-output"> <div class="mw-parser-output"><div class="mw-parser-output"> <div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] <div id="toc"> | + | <div class="mw-parser-output">__NOTOC__ <div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"> <div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] <div id="toc"> |
= Table of Contents = | = Table of Contents = | ||
<div style="margin-left: 1em">[[#Current_Status|Current Status]]</div> <div style="margin-left: 1em">[[#Barriers_to_Access|Barriers to Access]]</div> <div style="margin-left: 1em">[[#Promising_Programs|Promising Programs]]</div> <div style="margin-left: 2em">[[#Promising_Programs-Texas_Department_of_State_Health_Services|Texas Department of State Health Services]]</div> <div style="margin-left: 2em">[[#Promising_Programs-Philly_Website|Philly Website]]</div> <div style="margin-left: 2em">[[#Promising_Programs-TLC_Awareness_Campaign|TLC Awareness Campaign]]</div> <div style="margin-left: 1em">[[#Tools_.26_Resources|Tools & Resources]]</div> <div style="margin-left: 1em">[[#Scorecard_Building|Scorecard Building]]</div> <div style="margin-left: 1em">[[#Resources_to_Investigate|Resources to Investigate]]</div> <div style="margin-left: 1em">[[#Sources|Sources]]</div> </div> | <div style="margin-left: 1em">[[#Current_Status|Current Status]]</div> <div style="margin-left: 1em">[[#Barriers_to_Access|Barriers to Access]]</div> <div style="margin-left: 1em">[[#Promising_Programs|Promising Programs]]</div> <div style="margin-left: 2em">[[#Promising_Programs-Texas_Department_of_State_Health_Services|Texas Department of State Health Services]]</div> <div style="margin-left: 2em">[[#Promising_Programs-Philly_Website|Philly Website]]</div> <div style="margin-left: 2em">[[#Promising_Programs-TLC_Awareness_Campaign|TLC Awareness Campaign]]</div> <div style="margin-left: 1em">[[#Tools_.26_Resources|Tools & Resources]]</div> <div style="margin-left: 1em">[[#Scorecard_Building|Scorecard Building]]</div> <div style="margin-left: 1em">[[#Resources_to_Investigate|Resources to Investigate]]</div> <div style="margin-left: 1em">[[#Sources|Sources]]</div> </div> | ||
| Line 39: | Line 39: | ||
= Resources to Investigate = | = Resources to Investigate = | ||
| − | [[ | + | [[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|More RTI ]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|on]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Improve Screening for Infectious Disease among Opioid Users]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span> |
{| class="wiki_table" | {| class="wiki_table" | ||
| Line 61: | Line 61: | ||
## | ## | ||
##*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670662/ [5]] | ##*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670662/ [5]] | ||
| − | </div> </div> </div> </div> </div> | + | </div> </div> </div> </div> </div> </div> |
Revision as of 23:09, 6 January 2019
Return to Opioid Top-Level Strategy Map or Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)
Table of Contents
Current Status
- Hep C virus (HCV) infections tripled between 2010 and 2015
- Substance abuse and infectious diseases shared common populations, risk factors, social determinants, and even contracting venues[1]
- There was little collaboration between programs that provided services to these populations[2]
- Methadone clinics would be optimal venues for service integration because these clinics serve a population that is 60% injection drug users; have medical staff performing brief health assessments for all new clients; and already have some infectious disease screenings in place, including routine tuberculosis testing and intermittent opt-in HIV testing[3]
- One study showed that 68% of opioid treatment programs nationwide had staff capacity for HCV testing, but only 33% actually offered on-site HCV testing[4]
- Awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior
Barriers to Access
Promising Programs
Texas Department of State Health Services
[1]
Philly Website
phillyhepatits.org is an example of a resource for people seeking to identify if they have hepatitis, next steps they can take, and where they can find care or assistance.
TLC Awareness Campaign
"Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign provides information about how HCV infection is transmitted, risk factors for the disease, the importance of screening and treatment, and the availability of improved treatment for the disease.
Tools & Resources
TR - Improve Screening for Infectious Disease among Opioid Users
Scorecard Building
Potential Objective Details
Potential Measures and Data Sources
Potential Actions and Partners
Resources to Investigate
More RTI onImprove Screening for Infectious Disease among Opioid Users
PAGE MANAGER: [insert name here]
SUBJECT MATTER EXPERT: [fill out table below]
| Reviewer | Date | Comments |
